Elekta (OTCMKTS:EKTAY) Shares Gap Down – Time to Sell?
by Doug Wharley · The Cerbat GemElekta AB (OTCMKTS:EKTAY – Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $5.9950, but opened at $5.76. Elekta shares last traded at $5.76, with a volume of 249 shares traded.
Wall Street Analyst Weigh In
EKTAY has been the subject of a number of recent analyst reports. UBS Group began coverage on Elekta in a research report on Wednesday, September 3rd. They issued a “sell” rating for the company. Zacks Research raised shares of Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 16th. Three analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce”.
View Our Latest Research Report on EKTAY
Elekta Price Performance
The firm has a 50 day moving average price of $5.11 and a 200 day moving average price of $5.06. The stock has a market capitalization of $2.12 billion, a PE ratio of 19.79 and a beta of 1.04. The company has a current ratio of 1.05, a quick ratio of 0.82 and a debt-to-equity ratio of 0.63.
Elekta (OTCMKTS:EKTAY – Get Free Report) last released its quarterly earnings results on Wednesday, November 26th. The company reported $0.07 earnings per share (EPS) for the quarter. Elekta had a return on equity of 12.06% and a net margin of 1.62%.The business had revenue of $427.85 million during the quarter, compared to analyst estimates of $436.91 million. Research analysts anticipate that Elekta AB will post 0.36 earnings per share for the current year.
Elekta Company Profile
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.